L3VLUP
ProSign in

ATRC · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ATRCJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ATRC
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterATRCJNJ
Q3 20203 holders, $30m30 holders, $26.2bn
Q4 20204 holders, $73m32 holders, $26.6bn
Q1 20215 holders, $254m31 holders, $25.3bn
Q2 20214 holders, $278m37 holders, $25.6bn
Q3 20214 holders, $273m40 holders, $24.1bn
Q4 20213 holders, $254m33 holders, $25.2bn
Q1 20223 holders, $268m35 holders, $28.2bn
Q2 20222 holders, $165m33 holders, $26.9bn
Q3 20223 holders, $162m36 holders, $25.4bn
Q4 20222 holders, $159m35 holders, $27.6bn
Q1 20233 holders, $155m42 holders, $24.5bn
Q2 20234 holders, $211m38 holders, $25.0bn
Q3 20234 holders, $201m37 holders, $18.9bn
Q4 20233 holders, $125m31 holders, $19.0bn
Q1 20242 holders, $140m32 holders, $19.7bn
Q2 20242 holders, $109m35 holders, $20.4bn
Q3 20244 holders, $151m28 holders, $22.3bn
Q4 20244 holders, $157m37 holders, $20.4bn
Q1 202510 holders, $284m32 holders, $20.5bn
Q2 20256 holders, $335m31 holders, $18.4bn
Q3 20254 holders, $290m32 holders, $23.7bn
Q4 20256 holders, $381m29 holders, $27.8bn
Q1 20263 holders, $178m34 holders, $35.6bn
Q2 20263 holders, $125m33 holders, $39.1bn
ATRC

Atricure Inc

Holders
3
Reported value
$178m
Buyers
18
Sellers
13

Breadth +5 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
34
Reported value
$35.6bn
Buyers
21
Sellers
18

Breadth +3 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2026

Among the 35 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ATRC (1)

First Eagle Investment Management LLC

Only JNJ (32)

Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Farallon Capital Management LLC, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Rokos Capital Management LLP, Soros Fund Management LLC, and 7 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →